Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8026)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 28, 2021 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | State M, Negreanu L, Voiosu T, Voiosu A, Balanescu P, Mateescu RB. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. World J Gastroenterol 2021; 27(16): 1828-1840 [PMID: 33967560 DOI: 10.3748/wjg.v27.i16.1828] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i16/1828.htm |
| Number | Citing Articles |
| 1 |
Seung Bum Lee, Hyun-Ki Kim, Sang Hyuk Park, Ji-Hun Lim, Sang Hyoung Park. Ischemia-modified albumin: a novel blood marker of endoscopic mucosal healing in inflammatory bowel disease. Intestinal Research 2024; 22(1): 75 doi: 10.5217/ir.2023.00065
|
| 2 |
Monica State, Paul Balanescu, Theodor Voiosu, Andreea Bengus, Andrei Voiosu, Andrei Coman, Petronel Mustatea, Lucian Negreanu, Radu Bogdan Mateescu, Cristiana Popp. Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study. Biomedicines 2023; 11(7): 1860 doi: 10.3390/biomedicines11071860
|
| 3 |
Min Wang, Jingyan Shi, Chao Yu, Xinyi Zhang, Gaoxin Xu, Ziyan Xu, Yong Ma. Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds?. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1298186
|
| 4 |
Toshiyuki Sakurai, Masayuki Saruta. Positioning and Usefulness of Biomarkers in Inflammatory Bowel Disease. Digestion 2023; 104(1): 30 doi: 10.1159/000527846
|
| 5 |
Lauri Polari, Mervi Tenhami, Santeri Anttila, Terhi Helenius, Harry Kujari, Markku Kallajoki, Markku Voutilainen, Diana M. Toivola. Colonocyte keratin 7 is expressed de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-26603-2
|
| 6 |
Markus F Neurath, Michael Vieth. Different levels of healing in inflammatory bowel diseases: mucosal, histological, transmural, barrier and complete healing. Gut 2023; 72(11): 2164 doi: 10.1136/gutjnl-2023-329964
|
| 7 |
Fabio Corsi, Luca Sorrentino, Sara Albasini, Francesco Colombo, Maria Cigognini, Alessandro Massari, Carlo Morasso, Serena Mazzucchelli, Francesca Piccotti, Sandro Ardizzone, Gianluca M. Sampietro, Marta Truffi. Circulating Fibroblast Activation Protein as Potential Biomarker in Patients With Inflammatory Bowel Disease. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.725726
|
| 8 |
Hisashi Hirayama, Yasuhiro Morita, Takayuki Imai, Kenichiro Takahashi, Atsushi Yoshida, Shigeki Bamba, Osamu Inatomi, Akira Andoh. Ustekinumab trough levels predicting laboratory and endoscopic remission in patients with Crohn’s disease. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02271-4
|
| 9 |
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, M. V. Shashkov, A. S. Sokolova, I. N. Yakovina, A. V. Borisova. Fatty Acids of Erythrocyte Membranes and Blood Serum in Differential Diagnosis of Inflammatory Bowel Diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 32(4): 50 doi: 10.22416/1382-4376-2022-32-4-50-67
|
| 10 |
Jessica R Allegretti, Liliana G Bordeianou, Oriana M Damas, Samuel Eisenstein, Ruby Greywoode, Phillip Minar, Siddharth Singh, Sabrina Harmon, Eugene Lisansky, Myisha Malone-King, Nicole S Litwin, Alandra Weaver, Caren A Heller, Alan C Moss, Jeremy Adler. Challenges in IBD Research 2024: Pragmatic Clinical Research. Inflammatory Bowel Diseases 2024; 30(Supplement_2): S55 doi: 10.1093/ibd/izae083
|
| 11 |
Ellen Cristina Souza de Oliveira, Ana Elisa Valencise Quaglio, Thais Gagno Grillo, Luiz Claudio Di Stasi, Ligia Yukie Sassaki. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?. World Journal of Gastroenterology 2024; 30(16): 2184-2190 doi: 10.3748/wjg.v30.i16.2184
Abstract(293) |
Core Tip(356) |
Full Article(HTML)(1348)
|
Full Article with Cover (PDF)-2106K(58)
|
Audio-86K(16)
|
Peer-Review Report-201K(25)
|
Answering Reviewers-76K(27)
|
Supplementary Material-599K(36)
|
Full Article (PDF)-1871K(99)
|
Full Article (XML)-102K(28)
|
Times Cited (2)
|
Total Visits (3149)
|
Open
|
| 12 |
Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 2021; 11(12): 1375 doi: 10.3390/life11121375
|
| 13 |
Kacper Nijakowski, Rafał Rutkowski, Piotr Eder, Katarzyna Korybalska, Janusz Witowski, Anna Surdacka. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease. Life 2021; 11(12): 1409 doi: 10.3390/life11121409
|
| 14 |
M. Pehrsson, M. S. Alexdóttir, M. A. Karsdal, P. Thakker, J.H. Mortensen. Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn’s disease. Expert Review of Gastroenterology & Hepatology 2023; 17(6): 575 doi: 10.1080/17474124.2023.2212158
|
| 15 |
Marcia Henriques de Magalhães Costa, Ligia Yukie Sassaki, Júlio Maria Fonseca Chebli. Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease. World Journal of Gastroenterology 2024; 30(24): 3022-3035 doi: 10.3748/wjg.v30.i24.3022
|
| 16 |
Sophie Vieujean, Romain Gillard, Pierre Delanaye, Laurence Seidel, Emeline Bequet, Catherine Salée, Marie-Alice Meuwis, Charlotte Massot, Nicolas Pierre, Paul Meunier, Etienne Cavalier, Edouard Louis. Matrix gla protein, a potential marker of tissue remodelling and physiological ageing of the gut in crohn’s disease. Scandinavian Journal of Gastroenterology 2024; 59(3): 296 doi: 10.1080/00365521.2023.2286913
|
| 17 |
Yilin Wu, Jun Shen. Unraveling the intricacies of neutrophil extracellular traps in inflammatory bowel disease: Pathways, biomarkers, and promising therapies. Cytokine & Growth Factor Reviews 2024; doi: 10.1016/j.cytogfr.2024.10.003
|
| 18 |
Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51580-z
|
| 19 |
Anke L Nguyen, Claudia Brick, David Liu, David J Gibson, Peter R Gibson, Miles P Sparrow. Clinical utility of C‐reactive protein‐to‐albumin ratio in the management of patients with inflammatory bowel disease. JGH Open 2024; 8(4) doi: 10.1002/jgh3.13059
|